In 2021, the global opioid use disorder market was valued at approximately $2.8 billion. Projections indicate that this figure will reach $8.1 billion by 2031, representing a CAGR of 11.5% from 2022 to 2031. This substantial growth underscores the increasing recognition of OUD as a critical public health issue and the corresponding demand for effective treatments. The global opioid use disorder market has witnessed significant growth in recent years, reflecting the escalating challenges posed by opioid addiction worldwide. Opioid use disorder (OUD) is a chronic medical condition characterized by a compulsive urge to use opioids, increased tolerance, and withdrawal symptoms upon cessation. The disorder not only affects individuals’ health but also has profound social and economic implications.
Opioid Use Disorder Market Growth Factors
Several factors contribute to the rapid expansion of the opioid use disorder market:
1. Rising Prevalence of Chronic Diseases: The increase in chronic conditions such as cancer, cardiovascular diseases, and orthopedic ailments has led to a higher incidence of surgical interventions. Postoperative pain management often involves opioid prescriptions, which, while effective for pain relief, carry a risk of dependency. Consequently, there’s a heightened demand for treatments addressing opioid dependence arising from medical use.
2. Product Launches and Approvals: The pharmaceutical industry has seen a surge in the development and approval of medications targeting OUD. For instance, in May 2020, Indivior PLC announced the approval of Subutex, a prolonged-release solution for injection, by the Swedish Medical Products Agency. Such advancements enhance the therapeutic options available to healthcare providers and patients.
3. Innovative Treatment Modalities: The adoption of buprenorphine patches is gaining traction as an effective treatment for OUD. Transdermal patches offer benefits such as consistent drug delivery, improved patient compliance, and reduced potential for misuse compared to traditional administration routes.
Get Sample PDF Copy: https://www.alliedmarketresearch.com/request-sample/A12303
Opioid Use Disorder Market Segmentation
Understanding the opioid use disorder market requires an analysis of its key segments:
1. By Drug Type:
◦ Agonists: This category includes medications like methadone and buprenorphine, which activate opioid receptors to reduce withdrawal symptoms and cravings. The agonist segment dominated the market in 2021, driven by the high prevalence of opioid abuse and the effectiveness of these treatments.
◦ Antagonists: Drugs such as naltrexone fall into this category. They work by blocking opioid receptors, preventing the euphoric effects of opioids and aiding in relapse prevention. The antagonist segment is expected to witness considerable growth due to ongoing research and development efforts.
2. By Age Group:
◦ 19 to 39 Years: This demographic accounted for the largest market share in 2021. The higher prevalence of opioid misuse in younger populations contributes to this trend.
◦ 40 to 59 Years: This group also represents a significant portion of the market, often due to chronic pain management leading to prolonged opioid use.
◦ 60 Years and Over: While smaller in comparison, this segment is growing as the elderly population increases and faces age-related health issues requiring pain management.
3. By Route of Administration:
◦ Oral: Oral medications are commonly used due to their ease of administration and patient acceptance.
◦ Intravenous: This route is preferred in clinical settings for rapid drug delivery, especially in acute cases. The intravenous segment dominated the market in 2021, reflecting its effectiveness in managing severe withdrawal symptoms.
◦ Sublingual: Medications administered under the tongue offer quick absorption and are used for both maintenance therapy and detoxification.
4. By Distribution Channel:
◦ Hospital Pharmacies: These facilities accounted for the largest share in 2021, attributed to the increasing number of hospital admissions for OUD treatment and the availability of specialized care.
◦ Retail Pharmacies: Accessible to the general public, retail pharmacies play a crucial role in dispensing maintenance medications and providing patient education.
Regional Insights
Geographically, North America led the opioid use disorder market in 2021, driven by a high prevalence of OUD and well-established healthcare infrastructure. The region’s focus on addressing the opioid crisis through policy initiatives and funding has further propelled market growth.
Asia-Pacific is anticipated to register the fastest CAGR during the forecast period. Factors such as increasing awareness of OUD, improving healthcare services, and a growing geriatric population contribute to this trend. Countries in this region are investing in healthcare infrastructure and implementing programs to manage and prevent opioid addiction.
Key Players in the Opioid Use Disorder Market
The opioid use disorder market comprises several key players dedicated to developing and providing effective treatments. Notable companies include:
• Indivior PLC
• Alkermes
• AstraZeneca Plc.
• BioDelivery Sciences International Inc.
• Braeburn
• Camurus
• Cerebral
• Dr. Reddy’s Laboratories Ltd.
• Hikma Pharmaceuticals
• Mallinckrodt Pharmaceuticals
• Opiant Pharmaceuticals
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
The opioid use disorder market is experiencing rapid growth due to the increasing burden of opioid addiction and the urgent need for effective treatment solutions. With a projected CAGR of 11.5% from 2022 to 2031, the market will continue to evolve as new therapeutic innovations, regulatory support, and public health initiatives shape its trajectory.
As stakeholders across the healthcare sector collaborate to combat the opioid crisis, the future holds promise for improved patient outcomes, enhanced accessibility to treatment, and a more comprehensive approach to managing opioid addiction.
Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
- Which region has more opportunities?
By Region Outlook
- North America
(U.S., Canada, Mexico)
- Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
- Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
- LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain
